Baudax Bio, Inc. Quarterly Operating Income (Loss) in USD from Q3 2018 to Q3 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Baudax Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2018 to Q3 2023.
- Baudax Bio, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$1.78M, a 50.3% increase year-over-year.
- Baudax Bio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$16.4M, a 293% decline year-over-year.
- Baudax Bio, Inc. annual Operating Income (Loss) for 2022 was -$17.9M, a 29.8% increase from 2021.
- Baudax Bio, Inc. annual Operating Income (Loss) for 2021 was -$25.5M, a 65.9% increase from 2020.
- Baudax Bio, Inc. annual Operating Income (Loss) for 2020 was -$74.8M, a 130% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)